AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate) receptors desensitize rapidly and completely in the continued presence of their endogenous ligand glutamate; however, it is not clear what role AMPA receptor desensitization plays in the brain. We generated a knock-in mouse in which a single amino acid residue, which controls desensitization, was mutated in the GluA2 (GluR2) receptor subunit (GluA2 L483Y ). This mutation was homozygous lethal. However, mice carrying a single mutated allele, GluA2 L483Y/wt , survived past birth, but displayed severe and progressive neurological deficits including seizures and, ultimately, increased mortality. The expression of the AMPA receptor subunits GluA1 and GluA2 was decreased, whereas NMDA receptor protein expression was increased in GluA2 L483Y/wt mice. Despite this, basal synaptic transmission and plasticity in the hippocampus were largely unaffected, suggesting that neurons preferentially target receptors to synapses to normalize synaptic weight. We found no gross neuroanatomical alterations in GluA2 L483Y/wt mice. Moreover, there was no accumulation of AMPA receptor subunits in intracellular compartments, suggesting that folding and assembly of AMPA receptors are not affected by this mutation. Interestingly, EPSC paired pulse ratios in the CA1 were enhanced without a change in synaptic release probability, demonstrating that postsynaptic receptor properties can contribute to facilitation. The dramatic phenotype observed in this study by the introduction of a single amino acid change demonstrates an essential role in vivo for AMPA receptor desensitization.MPA receptors are tetramers assembled from the four receptor subunits GluA1-GluA4 (GluR1-4) (1). These receptors are activated by their endogenous ligand glutamate, and rapidly undergo desensitization within milliseconds of glutamate binding. Desensitization involves a conformational change of the receptor complex that allows closure of the channel gate while glutamate remains bound to the receptor (2). Synaptic currents are predominantly mediated by AMPA receptors at most excitatory synapses; therefore there has been interest in the development of pharmacological agents that enhance AMPA receptor function by limiting receptor deactivation and desensitization (3). There are many clear examples of synapses at which postsynaptic receptor desensitization plays a major role in synaptic depression (4-6). Many of these synapses are specialized structures in which glutamate remains in the synaptic cleft for prolonged periods of time during normal operation of the synapse (7). In contrast, at synapses where cleft glutamate is cleared rapidly or where AMPA receptor stoichiometry has become specialized to support high frequency transmission, there is little evidence that synaptic receptor desensitization has much influence on shaping the kinetics of transmission, and it is likely that receptor deactivation is the primary determinant of EPSC time-course (8-10).To determine the importance of AMPA receptor desensitizatio...